Panteli Aikaterini E, Theofilis Panagiotis, Vordoni Aikaterini, Vlachopanos Georgios, Koukoulaki Maria, Kalaitzidis Rigas G
Department of Internal Medicine, University Ηospital of Ioannina, Ioannina, Greece.
Center for Nephrology "G. Papadakis", General Hospital of Nikaia - Piraeus "Agios Panteleimon", Piraeus, Nikaia 18454, Greece.
Curr Vasc Pharmacol. 2022;20(2):168-177. doi: 10.2174/1570161119666211119142746.
The role of vitamin D in maintaining a healthy cardiovascular (CV) and the renal system has received increasing attention. Low vitamin D levels are associated with the incidence of hypertension, cardiac remodeling, and chronic congestive heart failure. Low vitamin D levels also influence renal disease progression and albuminuria deterioration. Moreover, recent research indicates that vitamin D deficiency can be a potential risk factor for coronavirus disease-19 (COVID-19) infection and poorer outcomes. Data are inconclusive as to whether supplementation with vitamin D agents reduces CV disease risk or COVID-19 severity. Conversely, in patients with kidney disease, vitamin D supplementation is associated with an improvement in kidney function and albuminuria. This narrative review considers recent data on the effects of vitamin D on the CV and renal system, as well as its possible role regarding COVID-19 complications.
维生素D在维持心血管(CV)和肾脏系统健康方面的作用受到了越来越多的关注。维生素D水平低与高血压、心脏重塑和慢性充血性心力衰竭的发生率相关。低维生素D水平还会影响肾脏疾病进展和蛋白尿恶化。此外,最近的研究表明,维生素D缺乏可能是冠状病毒病19(COVID-19)感染和较差预后的潜在风险因素。关于补充维生素D制剂是否能降低心血管疾病风险或COVID-19严重程度的数据尚无定论。相反,在肾病患者中,补充维生素D与肾功能和蛋白尿的改善相关。这篇叙述性综述考虑了关于维生素D对心血管和肾脏系统影响的最新数据,以及其在COVID-19并发症方面可能发挥的作用。